Skip to main content
Sionna Therapeutics, Inc. (SION)
Sionna Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Sionna Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 TTM Dec '23 Dec '22
Selling, General & Admin
-9.716.77
Research & Development
-40.6334.61
Operating Expenses
-50.3341.37
Operating Income
-65.02-50.33-41.37
Interest Expense / Income
-6.6-2.77-1.13
Other Expense / Income
-0.7-0.3-
Pretax Income
-57.72-47.26-40.24
Net Income
-57.72-47.26-40.24
Free Cash Flow
-48.58-44.82-37.94
EBITDA
-65.92-50.13-41.65
Depreciation & Amortization
-1.6-0.1-0.28
EBIT
-64.32-50.03-41.37
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).